Datopotamab Deruxtecan (Dato-DXd) — clinical trials using this drug

Public-registry trials using Datopotamab Deruxtecan (Dato-DXd) that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)	Eddingpharm (Zhuhai) Co., Ltd.	Breast Cancer (Locally Advanced or Metastatic)	PHASE1 / PHASE2	0

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →